Bolest srpastih ćelija (pedijatrija)
Zbrinjavanje vazo-okluzivne krize i akutnog grudnog sindroma
Kontrolisanje bola
What is the best pharmacologic treatment for sickle cell disease pain crises? (otvara novi prozor)
Izvor: Ann Emerg Med 2012;59(6):515-6.
Indeks: PubMed 22221839
DOI: 10.1016/j.annemergmed.2011.11.026
https://www.ncbi.nlm.nih.gov/pubmed/22221839 (otvara novi prozor)
Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (otvara novi prozor)
Izvor: Pediatr Blood Cancer 2009;53(3):401-5.
Indeks: PubMed 19422031
DOI: 10.1002/pbc.22048
https://www.ncbi.nlm.nih.gov/pubmed/19422031 (otvara novi prozor)
Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (otvara novi prozor)
Izvor: Thromb Haemost 2007;98(2):392-6.
Indeks: PubMed 17721622
https://www.ncbi.nlm.nih.gov/pubmed/17721622 (otvara novi prozor)
Terapija hidracijom (Terapija fluidima)
Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (otvara novi prozor)
Izvor: Cochrane Database Syst Rev 2012;(6):CD005406.
Indeks: PubMed 22696351
DOI: 10.1002/14651858.CD005406.pub3
https://www.ncbi.nlm.nih.gov/pubmed/22696351 (otvara novi prozor)
Terapija kiseonikom
Guidelines for the management of the acute painful crisis in sickle cell disease. (otvara novi prozor)
Izvor: Br J Haematol 2003;120(5):744-52.
Indeks: PubMed 12614204
https://www.ncbi.nlm.nih.gov/pubmed/12614204 (otvara novi prozor)
Antibiotska i respiratorna terapija
The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (otvara novi prozor)
Izvor: J Pediatr Hematol Oncol 2011;33(6):415-20.
Indeks: PubMed 21792036
DOI: 10.1097/MPH.0b013e31821ed4ce
https://www.ncbi.nlm.nih.gov/pubmed/21792036 (otvara novi prozor)
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (otvara novi prozor)
Izvor: Hemoglobin 2004;28(2):85-102.
Indeks: PubMed 15182051
https://www.ncbi.nlm.nih.gov/pubmed/15182051 (otvara novi prozor)
Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (otvara novi prozor)
Izvor: Blood 1998;92(9):3082-9.
Indeks: PubMed 9787142
https://www.ncbi.nlm.nih.gov/pubmed/9787142 (otvara novi prozor)
A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (otvara novi prozor)
Izvor: J Pediatr Hematol Oncol 2010;32(3):e91-4.
Indeks: PubMed 20216237
DOI: 10.1097/MPH.0b013e3181c29c52
https://www.ncbi.nlm.nih.gov/pubmed/20216237 (otvara novi prozor)
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (otvara novi prozor)
Izvor: Haematologica 2013;98(9):1375-82.
Indeks: PubMed 23645695
DOI: 10.3324/haematol.2013.086637
https://www.ncbi.nlm.nih.gov/pubmed/23645695 (otvara novi prozor)
Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (otvara novi prozor)
Izvor: JAMA 2003;289(9):1136-42.
Indeks: PubMed 12622584
https://www.ncbi.nlm.nih.gov/pubmed/12622584 (otvara novi prozor)
Predictors of bacteremia in febrile children with sickle cell disease. (otvara novi prozor)
Izvor: J Pediatr Hematol Oncol 2002;24(4):279-83.
Indeks: PubMed 11972096
https://www.ncbi.nlm.nih.gov/pubmed/11972096 (otvara novi prozor)